NPR

Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised

So far the government has distributed about 300,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.
Evusheld is treatment authorized to prevent COVID-19 in people who are seriously immunocompromised or have had serious adverse reactions to the vaccines.

Dr. Vivian Cheung takes steroids to manage a rare genetic disease. The drugs suppress her immune system, which puts her at high risk of getting very sick from COVID-19. It also means that her body didn't really make antibodies in response to two shots she got of the Moderna vaccine.

Cheung is a pediatrician and research scientist. Before the pandemic, from her clinic at the National Institutes of Health in Maryland to her lab at the University of Michigan. Now, she hasn't been to her lab in two years. "Except for work, I don't go out

You’re reading a preview, subscribe to read more.

More from NPR

NPR3 min read
Hobbyist Photographer Snaps Photo Of Extremely Rare Bird In 1st U.S. Sighting
Michael Sanchez was testing out his new camera when he happened upon a feathered subject. The blue rock-thrush he photographed on the coast of northern Oregon last week has excited the birding world.
NPR3 min read
Apple Shows Its Steepest Quarterly Decline In IPhone Sales Since Pandemic's Outset
The 10% drop in year-over-year iPhone sales for the January-March period is latest sign of weakness in a product that generates most of Apple's revenue.
NPR5 min read
Can You Survive Summer Indoors Without AC? In Arizona, Many Don’t
Nearly half of the people who suffered heat-related deaths in Arizona last year lived outdoors without shelter, but public health officials and lawmakers are starting to pay more attention to the risk of dying indoors.

Related Books & Audiobooks